chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Fatigue, Headache, Influenza like illness
Clinical narrative: flu like symptoms; Loss of Appetite; headache; achy; Extreme Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), DECREASED APPETITE (Loss of Appetite), HEADACHE (headache), MYALGIA (achy) and FATIGUE (Extreme Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     Concurrent medical conditions included Hypertension.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), DECREASED APPETITE (Loss of Appetite), HEADACHE (headache) and FATIGUE (Extreme Fatigue). 04-Mar-2021, the patient experienced MYALGIA (achy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), DECREASED APPETITE (Loss of Appetite), HEADACHE (headache), MYALGIA (achy) and FATIGUE (Extreme Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Body temperature: high (High) elevated temperature.         In concomitant medications high blood pressure medications were reported.   This case was linked to MOD-2021-052953 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: flu like symptoms; Loss of Appetite; headache; achy; Extreme Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), DECREASED APPETITE (Loss of Appetite), HEADACHE (headache), MYALGIA (achy) and FATIGUE (Extreme Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     Concurrent medical conditions included Hypertension.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), DECREASED APPETITE (Loss of Appetite), HEADACHE (headache) and FATIGUE (Extreme Fatigue). 04-Mar-2021, the patient experienced MYALGIA (achy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), DECREASED APPETITE (Loss of Appetite), HEADACHE (headache), MYALGIA (achy) and FATIGUE (Extreme Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Body temperature: high (High) elevated temperature.         In concomitant medications high blood pressure medications were reported.   This case was linked to MOD-2021-052953 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pain in extremity, Product dose omission issue, Vomiting
Clinical narrative: was dizzy; missed her appointment; soreness of arm; nauseous; threw up; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (was dizzy), PRODUCT DOSE OMISSION ISSUE (missed her appointment), PAIN IN EXTREMITY (soreness of arm), NAUSEA (nauseous) and VOMITING (threw up) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concomitant products included INSULIN HUMAN, INSULIN HUMAN INJECTION, ISOPHANE (NOVOLIN 70/30), CARVEDILOL, METOLAZONE, TORSEMIDE, PRAVASTATIN and POTASSIUM CHLORIDE for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced DIZZINESS (was dizzy), PRODUCT DOSE OMISSION ISSUE (missed her appointment), PAIN IN EXTREMITY (soreness of arm), NAUSEA (nauseous) and VOMITING (threw up). On 18-Mar-2021, PRODUCT DOSE OMISSION ISSUE (missed her appointment) had resolved. At the time of the report, DIZZINESS (was dizzy), PAIN IN EXTREMITY (soreness of arm), NAUSEA (nauseous) and VOMITING (threw up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details reported.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received the 2nd Moderna vaccine on 27Feb2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the 2nd Moderna vaccine on 27Feb2021) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history).   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the 2nd Moderna vaccine on 27Feb2021). On 27-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the 2nd Moderna vaccine on 27Feb2021) had resolved. Not Related          No concomitant or treatment medications were reported.; Reporter's Comments: This report refers to a case of Inappropriate schedule of product administration, for mRNA-1273, lot # Unkonwn,  with no associated AEs.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity, Peripheral swelling
Clinical narrative: Arm was swollen from elbow to shoulder; Arm was red; Arm was hot; Arm aches so bad he can die; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen from elbow to shoulder), ERYTHEMA (Arm was red), FEELING HOT (Arm was hot) and PAIN IN EXTREMITY (Arm aches so bad he can die) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003b21a) for COVID-19 vaccination.     The patient's past medical history included Bone injury (trapezoid injury) on 16-Mar-2021. Concurrent medical conditions included Blood pressure high and Cholesterol.    On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen from elbow to shoulder), ERYTHEMA (Arm was red), FEELING HOT (Arm was hot) and PAIN IN EXTREMITY (Arm aches so bad he can die). At the time of the report, PERIPHERAL SWELLING (Arm was swollen from elbow to shoulder), ERYTHEMA (Arm was red), FEELING HOT (Arm was hot) and PAIN IN EXTREMITY (Arm aches so bad he can die) outcome was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Heart rate, Palpitations, Product dose omission issue
Clinical narrative: haven't received 2nd dose; fast heartbeat of over 200/pulse high; dizziness; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (fast heartbeat of over 200/pulse high), DIZZINESS (dizziness), PRODUCT DOSE OMISSION ISSUE (haven't received 2nd dose) and ARTHRALGIA (joint pain) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: flu vaccine. Past adverse reactions to the above products included No adverse reaction with flu vaccine. Concurrent medical conditions included Drug allergy (Citalopram), Drug allergy (Ciprofloxacin), Drug allergy (Metilprednisone), Anxiety and Heart rate increased (The patient sometimes get fast heartbeat but it did not long as long as it lasted after administration of Covid-19 vaccine). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMIN D3 for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ARTHRALGIA (joint pain). On 27-Feb-2021, the patient experienced DIZZINESS (dizziness). On 01-Mar-2021, the patient experienced PALPITATIONS (fast heartbeat of over 200/pulse high). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (haven't received 2nd dose). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, PALPITATIONS (fast heartbeat of over 200/pulse high), DIZZINESS (dizziness) and ARTHRALGIA (joint pain) was resolving and PRODUCT DOSE OMISSION ISSUE (haven't received 2nd dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Heart rate: 200 (High) Fast heartbeat.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No treatment details provided. Reported that patient hasn't gotten the second dose of vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Reporter's city, New event added. On 08-Jun-2021: Reporter's email address and event verbatim of Missed dose updated.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Goitre, Lymphadenopathy
Clinical narrative: swollen thyroid; difficulty breathing; swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes), GOITRE (swollen thyroid) and DYSPNOEA (difficulty breathing) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph nodes), GOITRE (swollen thyroid) and DYSPNOEA (difficulty breathing). At the time of the report, LYMPHADENOPATHY (swollen lymph nodes), GOITRE (swollen thyroid) and DYSPNOEA (difficulty breathing) outcome was unknown.            No concomitant medication was reported. No treatment medication was reported.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient under 18 years of age had Moderna vaccine; A spontaneous report was received from a consumer concerning a 16-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) resulting in the event, patient under 18 years of age had Moderna vaccine/ product administered to patient of inappropriate age.    The patient's medical history was not provided. No relevant concomitant medications were reported.    On 17 Mar 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: 026a21a) intramuscularly for prophylaxis of COVID-19 infection.   On 17 Mar 2021, the Moderna COVID vaccine was given to a 16- year old patient. No adverse event was reported by the patient after being given the vaccine. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the event, product administered to patient of inappropriate age, was considered resolved on 17 Mar 2021.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (16 year old female) for mRNA-1273 (lot number 026A21A) with no associated AEs reported.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature increased, Dizziness, Dysstasia, Eating disorder
Clinical narrative: sore arm; didn't have any energy; head hurt; nauseous; achy all over; low blood sugar; very dizzy; could hardly stand up; temperature was 99.8°F; weak; didn't felt too much like eating; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), EATING DISORDER (didn't felt too much like eating), HYPOGLYCAEMIA (low blood sugar), DIZZINESS (very dizzy) and DYSSTASIA (could hardly stand up) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced EATING DISORDER (didn't felt too much like eating). On 16-Mar-2021, the patient experienced HYPOGLYCAEMIA (low blood sugar), DIZZINESS (very dizzy), DYSSTASIA (could hardly stand up), BODY TEMPERATURE INCREASED (temperature was 99.8°F), ASTHENIA (weak), HEAD DISCOMFORT (head hurt), NAUSEA (nauseous) and MYALGIA (achy all over). On 17-Mar-2021, the patient experienced ASTHENIA (didn't have any energy). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. On 15-Mar-2021, EATING DISORDER (didn't felt too much like eating) had resolved. On 16-Mar-2021, HYPOGLYCAEMIA (low blood sugar), DIZZINESS (very dizzy), DYSSTASIA (could hardly stand up), BODY TEMPERATURE INCREASED (temperature was 99.8°F), ASTHENIA (weak), HEAD DISCOMFORT (head hurt), NAUSEA (nauseous) and MYALGIA (achy all over) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm) and ASTHENIA (didn't have any energy) outcome was unknown.            Concomitant meds: unknown blood pressure medicine and unknown diabetes medication.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Hypoglycaemia, Myalgia, Nausea, Pain in extremity
Clinical narrative: sore arm; didn't have any energy; head hurt; nauseous; achy all over; low blood sugar; very dizzy; could hardly stand up; temperature was 99.8°F; weak; didn't felt too much like eating; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), EATING DISORDER (didn't felt too much like eating), HYPOGLYCAEMIA (low blood sugar), DIZZINESS (very dizzy) and DYSSTASIA (could hardly stand up) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced EATING DISORDER (didn't felt too much like eating). On 16-Mar-2021, the patient experienced HYPOGLYCAEMIA (low blood sugar), DIZZINESS (very dizzy), DYSSTASIA (could hardly stand up), BODY TEMPERATURE INCREASED (temperature was 99.8°F), ASTHENIA (weak), HEAD DISCOMFORT (head hurt), NAUSEA (nauseous) and MYALGIA (achy all over). On 17-Mar-2021, the patient experienced ASTHENIA (didn't have any energy). On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. On 15-Mar-2021, EATING DISORDER (didn't felt too much like eating) had resolved. On 16-Mar-2021, HYPOGLYCAEMIA (low blood sugar), DIZZINESS (very dizzy), DYSSTASIA (could hardly stand up), BODY TEMPERATURE INCREASED (temperature was 99.8°F), ASTHENIA (weak), HEAD DISCOMFORT (head hurt), NAUSEA (nauseous) and MYALGIA (achy all over) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm) and ASTHENIA (didn't have any energy) outcome was unknown.            Concomitant meds: unknown blood pressure medicine and unknown diabetes medication.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance
Clinical narrative: started walking funny/cannot walk properly/cannot walk unless he has a cane; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (started walking funny/cannot walk properly/cannot walk unless he has a cane) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21 and 024M20A) for COVID-19 vaccination.     Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), OMEPRAZOLE and PANTOPRAZOLE for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced GAIT DISTURBANCE (started walking funny/cannot walk properly/cannot walk unless he has a cane). At the time of the report, GAIT DISTURBANCE (started walking funny/cannot walk properly/cannot walk unless he has a cane) outcome was unknown.     Action taken with mRNA-1273 in response to the events was not applicable   Concomitant medications includes Bromphen/pseudo/dextro HBR syrup No treatment medications provided
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Inappropriate age for Vaccine Administration; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age for Vaccine Administration) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age for Vaccine Administration). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Inappropriate age for Vaccine Administration) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include high blood pressure medications. Treatment details included Tylenol.   This case was linked to MOD-2021-052934 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up email added, Patient age updated, Inappropriate age for Vaccine Administration
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness postural, Fatigue, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS POSTURAL (dizzy when he stand up), FATIGUE (fatigue) and NAUSEA (nausea) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012120A and 010M20A) for COVID-19 vaccination. Concomitant products included AMLODIPINE, LOSARTAN and METFORMIN for an unknown indication. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS POSTURAL (dizzy when he stand up), FATIGUE (fatigue) and NAUSEA (nausea). At the time of the report, DIZZINESS POSTURAL (dizzy when he stand up), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest pain, Illness, Myalgia, Nausea
Clinical narrative: she has not taken 2nd dose; Feeling really sick; chest hurts; Nausea; body ache; Arm started hurting; no energy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm started hurting), ASTHENIA (no energy), ILLNESS (Feeling really sick), CHEST PAIN (chest hurts) and NAUSEA (Nausea) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04GA21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm started hurting), ASTHENIA (no energy), NAUSEA (Nausea) and MYALGIA (body ache). On 22-Mar-2021, the patient experienced ILLNESS (Feeling really sick) and CHEST PAIN (chest hurts). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (she has not taken 2nd dose). At the time of the report, PAIN IN EXTREMITY (Arm started hurting), ASTHENIA (no energy), ILLNESS (Feeling really sick), CHEST PAIN (chest hurts), NAUSEA (Nausea), MYALGIA (body ache) and PRODUCT DOSE OMISSION ISSUE (she has not taken 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. Treatment information were  reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: TCR
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Product dose omission issue
Clinical narrative: she has not taken 2nd dose; Feeling really sick; chest hurts; Nausea; body ache; Arm started hurting; no energy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm started hurting), ASTHENIA (no energy), ILLNESS (Feeling really sick), CHEST PAIN (chest hurts) and NAUSEA (Nausea) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04GA21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm started hurting), ASTHENIA (no energy), NAUSEA (Nausea) and MYALGIA (body ache). On 22-Mar-2021, the patient experienced ILLNESS (Feeling really sick) and CHEST PAIN (chest hurts). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (she has not taken 2nd dose). At the time of the report, PAIN IN EXTREMITY (Arm started hurting), ASTHENIA (no energy), ILLNESS (Feeling really sick), CHEST PAIN (chest hurts), NAUSEA (Nausea), MYALGIA (body ache) and PRODUCT DOSE OMISSION ISSUE (she has not taken 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. Treatment information were  reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: TCR
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, COVID-19, Chills, Headache
Clinical narrative: Stuffy nose; Stomachache; Chills; Headache; Body aches; Joint pains; fever; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Stuffy nose), ABDOMINAL PAIN UPPER (Stomachache), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Body aches) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (He tested Positive for Covid in Feb2021) in February 2021.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced NASAL CONGESTION (Stuffy nose), ABDOMINAL PAIN UPPER (Stomachache), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Body aches), ARTHRALGIA (Joint pains) and PYREXIA (fever). At the time of the report, NASAL CONGESTION (Stuffy nose), ABDOMINAL PAIN UPPER (Stomachache), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Body aches), ARTHRALGIA (Joint pains) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, COVID-19: positive (Positive) Positive in Feb-2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment drugs were reported   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up received :Event outcome updated and declined to further follow-up
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nasal congestion, Pyrexia
Clinical narrative: Stuffy nose; Stomachache; Chills; Headache; Body aches; Joint pains; fever; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Stuffy nose), ABDOMINAL PAIN UPPER (Stomachache), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Body aches) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (He tested Positive for Covid in Feb2021) in February 2021.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced NASAL CONGESTION (Stuffy nose), ABDOMINAL PAIN UPPER (Stomachache), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Body aches), ARTHRALGIA (Joint pains) and PYREXIA (fever). At the time of the report, NASAL CONGESTION (Stuffy nose), ABDOMINAL PAIN UPPER (Stomachache), CHILLS (Chills), HEADACHE (Headache), MYALGIA (Body aches), ARTHRALGIA (Joint pains) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, COVID-19: positive (Positive) Positive in Feb-2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment drugs were reported   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up received :Event outcome updated and declined to further follow-up
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swollen arm around the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swollen arm around the injection site). At the time of the report, VACCINATION SITE SWELLING (swollen arm around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Hyperhidrosis, Keratosis pilaris, Pruritus
Clinical narrative: Bumps and dots on stomach; Redness on stomach; Itchiness on both arms; Bumps on both arms; Redness on both arms; Sweating profusely; Itchiness on back; Bumps and dots on back; Redness on back; Itchiness on stomach; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Mar-2021 and was forwarded to Moderna on 22-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness on back), KERATOSIS PILARIS (Bumps and dots on back), ERYTHEMA (Redness on back), PRURITUS (Itchiness on stomach) and KERATOSIS PILARIS (Bumps and dots on stomach) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Codeine) and Blood pressure high. Concomitant products included CANDESARTAN for Blood pressure high.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced PRURITUS (Itchiness on back), KERATOSIS PILARIS (Bumps and dots on back), ERYTHEMA (Redness on back) and PRURITUS (Itchiness on stomach). On an unknown date, the patient experienced KERATOSIS PILARIS (Bumps and dots on stomach), ERYTHEMA (Redness on stomach), PRURITUS (Itchiness on both arms), KERATOSIS PILARIS (Bumps on both arms), ERYTHEMA (Redness on both arms) and HYPERHIDROSIS (Sweating profusely). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and CORTISONE (topical) at an unspecified dose and frequency. At the time of the report, PRURITUS (Itchiness on back), KERATOSIS PILARIS (Bumps and dots on back), ERYTHEMA (Redness on back), PRURITUS (Itchiness on stomach), KERATOSIS PILARIS (Bumps and dots on stomach), ERYTHEMA (Redness on stomach), PRURITUS (Itchiness on both arms), KERATOSIS PILARIS (Bumps on both arms), ERYTHEMA (Redness on both arms) and HYPERHIDROSIS (Sweating profusely) outcome was unknown. Not Provided          Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: ADR form
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 y/o female who received 1st dose of Moderna Covid-19 vaccine in error; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 y/o female who received 1st dose of Moderna Covid-19 vaccine in error) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 19-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 y/o female who received 1st dose of Moderna Covid-19 vaccine in error). On 19-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 y/o female who received 1st dose of Moderna Covid-19 vaccine in error) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received 2nd shot of Vaccine after 7 weeks of 1st dose; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd shot of Vaccine after 7 weeks of 1st dose) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 25-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd shot of Vaccine after 7 weeks of 1st dose). On 25-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd shot of Vaccine after 7 weeks of 1st dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medications not provided Treatment information not provided; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273 (Lot number: Not Provided) with no associated AEs.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pain, Pain in extremity
Clinical narrative: Pain; Arm hurts; Soar arm; Knee hurts; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), PAIN IN EXTREMITY (Arm hurts), MYALGIA (Soar arm) and ARTHRALGIA (Knee hurts) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis and Diabetes. Concomitant products included OXYGEN for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN (Pain), PAIN IN EXTREMITY (Arm hurts), MYALGIA (Soar arm) and ARTHRALGIA (Knee hurts). At the time of the report, PAIN (Pain), PAIN IN EXTREMITY (Arm hurts), MYALGIA (Soar arm) and ARTHRALGIA (Knee hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications included rheumatoid arthritis and diabetic medications. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: No new information was updated.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Illness, Vaccination site erythema, Vaccination site induration, Vaccination site pruritus
Clinical narrative: Got very sick; Itchy at injection site; Arm swelling at the injection site; Hard knot at the injection site; Red at injection site; Threw up twice; Very bad chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Got very sick), VACCINATION SITE PRURITUS (Itchy at injection site), VACCINATION SITE SWELLING (Arm swelling at the injection site), VACCINATION SITE INDURATION (Hard knot at the injection site) and VACCINATION SITE ERYTHEMA (Red at injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. A44821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced ILLNESS (Got very sick), VACCINATION SITE PRURITUS (Itchy at injection site), VACCINATION SITE SWELLING (Arm swelling at the injection site), VACCINATION SITE INDURATION (Hard knot at the injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VOMITING (Threw up twice) and CHILLS (Very bad chills). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, ILLNESS (Got very sick), VACCINATION SITE PRURITUS (Itchy at injection site), VACCINATION SITE SWELLING (Arm swelling at the injection site), VACCINATION SITE INDURATION (Hard knot at the injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VOMITING (Threw up twice) and CHILLS (Very bad chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vomiting
Clinical narrative: Got very sick; Itchy at injection site; Arm swelling at the injection site; Hard knot at the injection site; Red at injection site; Threw up twice; Very bad chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Got very sick), VACCINATION SITE PRURITUS (Itchy at injection site), VACCINATION SITE SWELLING (Arm swelling at the injection site), VACCINATION SITE INDURATION (Hard knot at the injection site) and VACCINATION SITE ERYTHEMA (Red at injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. A44821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced ILLNESS (Got very sick), VACCINATION SITE PRURITUS (Itchy at injection site), VACCINATION SITE SWELLING (Arm swelling at the injection site), VACCINATION SITE INDURATION (Hard knot at the injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VOMITING (Threw up twice) and CHILLS (Very bad chills). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, ILLNESS (Got very sick), VACCINATION SITE PRURITUS (Itchy at injection site), VACCINATION SITE SWELLING (Arm swelling at the injection site), VACCINATION SITE INDURATION (Hard knot at the injection site), VACCINATION SITE ERYTHEMA (Red at injection site), VOMITING (Threw up twice) and CHILLS (Very bad chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Cannot get dose within the recommended time period; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Cannot get dose within the recommended time period) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Cannot get dose within the recommended time period). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Cannot get dose within the recommended time period) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information not provided.  Treatment information not provided.; Sender's Comments: This report refers to a case of Product dose omission issue for mRNA-1273, lot # unknown, with no associated AEs.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site warmth
Clinical narrative: warm area where vaccine was given; knot where vaccine was given; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm area where vaccine was given) and VACCINATION SITE MASS (knot where vaccine was given) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No medical history information were provided by the reporter.     On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE WARMTH (warm area where vaccine was given) and VACCINATION SITE MASS (knot where vaccine was given). At the time of the report, VACCINATION SITE WARMTH (warm area where vaccine was given) and VACCINATION SITE MASS (knot where vaccine was given) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Treatment information were not provided by the reporter..   Most recent FOLLOW-UP information incorporated above includes: On 09-May-2021
Sex: F
Vaccine: COVID19
Symptoms: Chills, Contusion, Dizziness, Headache, Heart rate increased
Clinical narrative: sick for five days; fast heartbeat; dizziness; read and bruised arm; muscle pain; chills; nausea; headache; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (muscle pain), CHILLS (chills), NAUSEA (nausea), HEADACHE (headache) and DIZZINESS (dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle pain), CHILLS (chills), NAUSEA (nausea), HEADACHE (headache), DIZZINESS (dizziness), HEART RATE INCREASED (fast heartbeat), ILLNESS (sick for five days) and CONTUSION (read and bruised arm). At the time of the report, MYALGIA (muscle pain), CHILLS (chills), NAUSEA (nausea), HEADACHE (headache), DIZZINESS (dizziness), HEART RATE INCREASED (fast heartbeat), ILLNESS (sick for five days) and CONTUSION (read and bruised arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Illness, Myalgia, Nausea
Clinical narrative: sick for five days; fast heartbeat; dizziness; read and bruised arm; muscle pain; chills; nausea; headache; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (muscle pain), CHILLS (chills), NAUSEA (nausea), HEADACHE (headache) and DIZZINESS (dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle pain), CHILLS (chills), NAUSEA (nausea), HEADACHE (headache), DIZZINESS (dizziness), HEART RATE INCREASED (fast heartbeat), ILLNESS (sick for five days) and CONTUSION (read and bruised arm). At the time of the report, MYALGIA (muscle pain), CHILLS (chills), NAUSEA (nausea), HEADACHE (headache), DIZZINESS (dizziness), HEART RATE INCREASED (fast heartbeat), ILLNESS (sick for five days) and CONTUSION (read and bruised arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Arthralgia, Chills, Dizziness
Clinical narrative: rash on arm; fever (101); Nausea; I experienced new loss of smell; dizziness; really bad fogginess; unable to woke up in the morning; loss of taste sensation; Headache; chills; severe joint pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (I experienced new loss of smell), DIZZINESS (dizziness), FEELING ABNORMAL (really bad fogginess), SLEEP DISORDER (unable to woke up in the morning) and AGEUSIA (loss of taste sensation) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced ANOSMIA (I experienced new loss of smell), DIZZINESS (dizziness), FEELING ABNORMAL (really bad fogginess), SLEEP DISORDER (unable to woke up in the morning), AGEUSIA (loss of taste sensation), HEADACHE (Headache), CHILLS (chills), ARTHRALGIA (severe joint pain), FATIGUE (fatigue), PYREXIA (fever (101)) and NAUSEA (Nausea). On 18-Mar-2021, the patient experienced RASH (rash on arm). The patient was treated with PARACETAMOL (TYLENOL) for Paracetamol, at an unspecified dose and frequency. On 17-Mar-2021, ANOSMIA (I experienced new loss of smell), FEELING ABNORMAL (really bad fogginess), SLEEP DISORDER (unable to woke up in the morning), AGEUSIA (loss of taste sensation), HEADACHE (Headache), CHILLS (chills), ARTHRALGIA (severe joint pain), FATIGUE (fatigue) and PYREXIA (fever (101)) had resolved. At the time of the report, DIZZINESS (dizziness) and NAUSEA (Nausea) had not resolved and RASH (rash on arm) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. Treatment included Tylenol
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Nausea, Pyrexia
Clinical narrative: rash on arm; fever (101); Nausea; I experienced new loss of smell; dizziness; really bad fogginess; unable to woke up in the morning; loss of taste sensation; Headache; chills; severe joint pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (I experienced new loss of smell), DIZZINESS (dizziness), FEELING ABNORMAL (really bad fogginess), SLEEP DISORDER (unable to woke up in the morning) and AGEUSIA (loss of taste sensation) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced ANOSMIA (I experienced new loss of smell), DIZZINESS (dizziness), FEELING ABNORMAL (really bad fogginess), SLEEP DISORDER (unable to woke up in the morning), AGEUSIA (loss of taste sensation), HEADACHE (Headache), CHILLS (chills), ARTHRALGIA (severe joint pain), FATIGUE (fatigue), PYREXIA (fever (101)) and NAUSEA (Nausea). On 18-Mar-2021, the patient experienced RASH (rash on arm). The patient was treated with PARACETAMOL (TYLENOL) for Paracetamol, at an unspecified dose and frequency. On 17-Mar-2021, ANOSMIA (I experienced new loss of smell), FEELING ABNORMAL (really bad fogginess), SLEEP DISORDER (unable to woke up in the morning), AGEUSIA (loss of taste sensation), HEADACHE (Headache), CHILLS (chills), ARTHRALGIA (severe joint pain), FATIGUE (fatigue) and PYREXIA (fever (101)) had resolved. At the time of the report, DIZZINESS (dizziness) and NAUSEA (Nausea) had not resolved and RASH (rash on arm) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. Treatment included Tylenol